Abstract

The search for effective plant-derived anti-cancer agents or their synthetic analogs has continued to gain interest in drug development. The anti-cancer activity of parthenolide (PTL) isolated from Tanacetum parthenium, has been attributed to the presence of α-methylene-γ-lactone skeleton. In the present study we aimed to investigate the anti-cancer potential of a new synthetic compound, 3-isopropyl-2-methyl-4-methyleneisoxazolidin-5-one (MZ-6), with the same as in PTL α-methylene-γ-lactone motif, on two breast cancer cell lines, MCF-7 and MDA-MB-231. For comparison, PTL was included in the study. PTL and MZ-6 reduced the number of viable MCF-7 and MDA-MB-231 cells, with half maximal inhibitory concentration values between 6 and 9 μM. Both compounds dose-dependently inhibited incorporation of [3H]thymidine, up-regulated Bax and down regulated Bcl-2 mRNA. The levels of the end product of lipid peroxidation, malondialdehyde, were significantly higher. In MCF-7 cells, MZ-6 induced early apoptosis and cell cycle arrest in G0/G1 phase. The effect produced by MZ-6 was much stronger compared with PTL. In MDA-MB-231 cells, both tested compounds had similar effect and induced mostly late apoptosis. In conclusion, the observed anticancer activity makes MZ-6 an attractive drug candidate and shows that simple analogs of α-methylene-γ-lactones can be good substitutes for more complex structures isolated from plants.

Highlights

  • Breast cancer is one of the leading causes of mortality among women in developed countries

  • Janecki Institute of Organic Chemistry, Technical University of Lodz, Lodz, Poland simple analogs of a-methylene-c-lactones can be good substitutes for more complex structures isolated from plants

  • Since the induction of apoptosis might be mediated through the cell cycle arrest, we examined the effect of PTL and MZ-6 on cell cycle perturbations

Read more

Summary

Introduction

Breast cancer is one of the leading causes of mortality among women in developed countries. 60 % of breast cancers are hormone-dependent and require estrogen for tumor growth [1]. Recent progress in diagnosis and therapy has increased the survival of women with estrogen-dependent breast cancer. In recent years the search for new anti-tumor substances obtained from plants has been a hot research activity. The sesquiterpene lactone, parthenolide (PTL), isolated from feverfew (Tanacetum parthenium) has been extensively studied in relation to its anti-cancer properties. PTL was shown in vitro to inhibit proliferation and induce apoptosis in various human cancers, such as colorectal cancer, hepatoma, cholangiocarcinoma and pancreatic cancer [2,3,4,5], but there have been no reports on its ability to induce apoptosis in breast cancer cells. The active fragment in the structure of PTL is an a-methylene-c-lactone skeleton which can react via the Michael type addition with mercapto groups of enzymes

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.